The contribution of GABAergic dysfunction to neurodevelopmental disorders
Name
Lin_The contribution of GAVAergic.pdf
Size
574.53 KB
Format
Adobe PDF
Checksum (MD5)
8dd311d7183e426e8f6d118faac99a8f
Author(s)
Ramamoorthi, Kartik
Lin, Yingxi
Date Issued
April 2011
Journal
Trends in Molecular Medicine
Publisher
Elsevier
Citation
Ramamoorthi, Kartik, and Yingxi Lin. “The Contribution of GABAergic Dysfunction to Neurodevelopmental Disorders.” Trends in Molecular Medicine 17, no. 8 (August 2011): 452–462.
Version
Author's final manuscript
Abstract
GABA (γ-aminobutyric acid) is the major inhibitory neurotransmitter in the brain. The GABAergic system is indispensable for maintaining the balance between excitation and inhibition (E/I balance) required for normal neural circuit function. E/I imbalances that result from perturbations in the development of this system, ranging from the generation of inhibitory neurons to the formation of their synaptic connections, have been implicated in several neurodevelopmental disorders. In this review, we discuss how impairments at different stages in GABAergic development can lead to disease states. We also highlight recent studies which show that modulation of the GABAergic system can successfully reverse cognitive deficits in disease models and suggest that therapeutic strategies targeting the GABAergic system could be effective in treating neurodevelopmental disorders.
MIT Department
Massachusetts Institute of Technology. Department of Brain and Cognitive Sciences
McGovern Institute for Brain Research at MIT
Terms of Use
Creative Commons Attribution-Noncommercial-NoDerivatives
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1016/j.molmed.2011.03.003
